Unlock stock picks and a broker-level newsfeed that powers Wall Street.
0.3800
+0.0100
+(2.70%)
At close: April 1 at 4:00:00 PM EDT
Research Analysis
Earnings Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | -- | -- | -- | -- |
Avg. Estimate | 0 | 0 | 0 | 0 |
Low Estimate | 0 | 0 | 0 | 0 |
High Estimate | 0 | 0 | 0 | 0 |
Year Ago EPS | -- | -- | -- | -- |
Revenue Estimate
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
No. of Analysts | 5 | 5 | 5 | 6 |
Avg. Estimate | 457.8k | 1.17M | 7.03M | 81.93M |
Low Estimate | -- | 460k | 3.19M | 35M |
High Estimate | 1.76M | 1.84M | 10M | 293.28M |
Year Ago Sales | -- | -- | -- | 7.03M |
Sales Growth (year/est) | 0.00% | 0.00% | 0.00% | 1,065.72% |
EPS Trend
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Current Estimate | 0 | 0 | 0 | 0 |
7 Days Ago | 0 | 0 | 0 | 0 |
30 Days Ago | 0 | 0 | 0 | 0 |
60 Days Ago | 0 | 0 | 0 | 0 |
90 Days Ago | 0 | 0 | 0 | 0 |
EPS Revisions
Currency in USD | Current Qtr. (Mar 2025) | Next Qtr. (Jun 2025) | Current Year (2025) | Next Year (2026) |
---|---|---|---|---|
Up Last 7 Days | -- | -- | -- | -- |
Up Last 30 Days | -- | -- | -- | -- |
Down Last 7 Days | -- | -- | -- | -- |
Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
Current Qtr. | Next Qtr. | Current Year | Next Year | |
---|---|---|---|---|
HUMAW | -- | -- | -- | -- |
S&P 500 | 6.69% | 6.80% | 9.98% | 14.34% |
Related Tickers
RCKTW Rocket Pharmaceuticals, Inc.
0.0467
-0.64%
IMTXW Immatics N.V.
0.0158
0.00%
COEPW Coeptis Therapeutics Holdings, Inc.
0.0080
-27.27%
ARGNF argenx SE
697.42
0.00%
LEXXW Lexaria Bioscience Corp.
0.3000
-7.69%
APLMW Apollomics, Inc.
0.0108
0.00%
SLNCF Silence Therapeutics plc
0.8450
-25.22%
IVBXF Innovent Biologics, Inc.
6.15
+4.24%
SLXNW Silexion Therapeutics Corp
0.0700
-0.14%
CNBX CNBX Pharmaceuticals Inc.
0.0100
+23.46%